Compound Detail
CHEMBL5905066
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
C[C@H]1OC(=O)[C@]2(C(O)C(N)=O)CC(F)(F)[C@@H](C)[C@H](/C=C/c3ccc(-c4ccccc4C#N)cn3)[C@H]12
Basic Information
| ChEMBL ID | CHEMBL5905066 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | UZVGVKOQRBQHDQ-LHCDKGINSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
481.5
MW (Da)
3.32
ALogP
6
HBA
2
HBD
126.3
PSA (Ų)
0.63
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 8.36
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Serine/threonine-protein kinase MARK2 CHEMBL3831 | IC50 | 8.36 | 8.36 | 4.4 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 4.22 | 4.22 | 60000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Serine/threonine-protein kinase MARK2 | IC50 | = | 4.41 | nM | 8.36 | PAR-1 FLIPR Assay: This assay measures the potency of the inventive compounds as... | - |
| Voltage-gated inwardly rectifying potassium channel KCNH2 | IC50 | = | 60000.0 | nM | 4.22 | MK-499 Filter Binding Assay: Drug cardiac arrhythmia is an important safety conc... | - |
Data from ChEMBL 36 via Core Engine